Financial Performance - The company's total revenue for 2022 was CNY 156,983,059.01, a decrease of 12.28% compared to the previous year[4] - Net profit attributable to shareholders was CNY 18,639,103.88, down 46.83% year-on-year[4] - Net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 11,083,899.76, a decline of 61.20% compared to the previous year[4] Assets and Equity - Total assets at the end of the reporting period reached CNY 431,797,051.00, an increase of 45.63% year-on-year[5] - Shareholders' equity attributable to the company was CNY 358,670,471.65, up 68.19% from the beginning of the period[5] - The increase in total assets and equity was primarily due to the issuance of shares to unspecified qualified investors and an increase in undistributed profits[6] Challenges and Market Conditions - The company faced challenges due to domestic pandemic restrictions affecting marketing activities and logistics, leading to lower revenue expectations[6] - The decline in revenue was also influenced by low pork prices and significant increases in feed raw material costs, resulting in reduced purchasing desire from farmers[6] Future Plans and Cautions - The company plans to enhance its marketing system and strengthen brand image to improve competitiveness and return better results to investors[5] - The company warns that the financial data presented is preliminary and unaudited, urging investors to be cautious[7]
大禹生物(871970) - 2022 Q4 - 年度业绩